Referees for Volume 32

The Editors of Journal of Biopharmaceutical Statistics would like to thank all of our reviewers for their contribution and support for Volume 32. High-quality peer review is essential to the success of the Journal and we greatly appreciate the dedication of all those who have contributed to this.

Table

Alan Wu	BMS
Alex Sverdlov	EMD Serono
Alexander de Leon	University of Calgary
Alexandre Trindade
Andrzej Kosinski	Duke University
Anqi Zhu	23andMe
Anqing Zhang	George Washington University
April Wang
B.Nebiyou Bekele	Exelixis Inc
Benjamin Lang	Boehringer Ingelheim Pharma GmbH & Co. KG
Bradley Hupf	Takeda Pharmaceuticals USA Inc.
Brett Hanscom	Fred Hutch Cancer Research Center
Cesar Torres	US Food and Drug Administration
Changxing Ma	University at Buffalo
Chaoran Hu	Eli Lilly and Company
Chengxue Zhong	Boehringer Ingelheim Corp. USA
Christopher Coffey	University of Iowa
Danqing Xu	AbbVie Biotherapeutics Inc.
Di Wu
Dixin Shen	Grail Inc.
Dong Xi	Novartis Pharmaceuticals Corporation
Douglas Faries	Eli Lilly and Company
Edson Zangiacomi Martinez	Universidade de Sao Paulo
Erina Paul	Merck & Co Inc
Fabio Rigat	Janssen-Cilag UK
Fanni Natanegara	Eli Lilly and Company
Feinan Lu
Frank Bretz	Novartis Pharmaceuticals Corporation
Fredrik Ohrn	AstraZeneca R&D
G. Niklas Noren	Uppsala Monitoring Centre
Gen Zhu	University of Texas Health Science Center at Houston School of Public Health
Grecio Sandoval	George Washington University Biostatistics Center
Greg Cicconetti	AbbVie Inc.
Guanbo Wang
Heinz Schmidli	Novartis Pharmaceuticals Corporation
Heng Zhou	Merck & Co Inc
Hongfei Li	University of Connecticut
Hongtao Zhang	Bristol-Myers Squibb
Hongwei Wang	AbbVie Inc.
Hui Quan	Sanofi-Aventis USA
Ilya Lipkovich	Eli Lilly and Company
Indranil Ghosh	University of North Carolina Wilmington
Inna Perevozskaya	GlaxoSmithKline
James Roger
Jessie Gu
Jianan Hui	Boehringer Ingelheim Pharmaceuticals Inc.
Jianchang Lin	Takeda Pharmaceuticals Inc.
Jianjin Xu	US Food and Drug Administration
Jiaxi Zhou	US Food and Drug Administration
Jin Liu	Vertex Pharmaceuticals Incorporated
John Preisser
John Lawrence	US Food and Drug Administration
Julia Zhu	Overland Pharmaceuticals
Kazushi Maruo	University of Tsukuba
Kentaro Sakamaki	Yokohama City University
Krishna K. Saha	Central Connecticut State University
Lei Gao
LiAn Lin	Moderna
Lifeng Lin	University of Arizona Mel and Enid Zuckerman College of Public Health
Linda Sun
Lu Mao	University of Wisconsin Madison
Luke Prendergast	La Trobe University
Marie Beisemann	TU Dortmund University
Melvin Munsaka	AbbVie Inc.
Miao Yang	Nektar Therapeutics
Miao-Yu Tsai	National Changhua University of Education
Michael Fay	NIAID
Michael LaValley	Boston University
Michael Grayling	Newcastle University Institute for Health and Society
Min Tang
Ming-Dauh Wang	Bayer HealthCare Pharmaceuticals Inc.
Nitin Nair	Vertex Pharmaceuticals Inc.
Palanikumar Ravindran	Bristol-Myers Squibb Co R&D Lawrence
Palash Ghosh
Pao-Sheng Shen	Tunghai University
Pei Zhang	University of Maryland at College Park
Peng Jin	New York University Grossman School of Medicine
Pete Philipson	Newcastle University
Peter Thall	M.D. Anderson Cancer Center
Qi Liu	Merck & Co Inc.
Qian Guan	Meta
Qian Li	Bristol-Myers Squibb Co.
Qing Li	MorphoSys US Inc.
Rachael Liu	Takeda Pharmaceuticals Inc.
Rajesh Nair	US Food and Drug Administration
Ran Bi	US Food and Drug Administration
Ran Liao	Eli Lilly and Company
Riccardo De Bin	University of Oslo
Ruosha Li	University of Texas Health Science Center at Houston
Sammy Yuan	Kite Pharma Inc.
Samvel Gasparyan	AstraZeneca R&D Gothenburg
Santu Ghosh	Georgia Regents University
Saptarshi Chatterjee	Eli Lilly and Company
Saurabh Mukhopadhyay	AbbVie Inc.
Seung-Chun Lee	Hanshin University
Shaobo Liu	US Food and Drug Administration
Shiling Ruan
Shrabanti Chowdhury	Icahn School of Medicine at Mount Sinai Department of Genetics and Genomic Sciences
Shu Jiang
Silke Jorgens	Janssen Pharmaceutical Companies of Johnson and Johnson
Stavros Nikolakopoulos	UMC Ultrecht
Steen Johan
Stefan Englert	Janssen Pharmaceutical Companies of Johnson and Johnson
Steven Novick	GlaxoSmithKline
Taban Baghfalaki	Tarbiat Modares University
Tao Liang	Johns Hopkins University School of Medicine
Tianyu Bai	University of Texas at San Antonio
Tibor Schuster	McGill University
Ting Ye	University of Washington
Tom Parke	Berry Consultants
Tomohiro Shinozaki	Tokyo University of Science – Katsushika Campus
Tomoyuki Kakizume	Takeda Pharmaceuticals Inc.
Torben Martinussen
Toshimitsu Hamasaki	George Washington University Biostatistics Center
Tulin Shekar
Vicky Yau
Wanjie Sun	US Food and Drug Administration
Wei Wang	Merck Research Laboratories
Wei Liang
Weihan Zhao	AbbVie Inc.
Wenjing Luo
Xiang Lu	US Food and Drug Administration
Xiao Tian	Visa Inc.
Xiaotian Chen	AbbVie Inc.
Xin Sean Chen	AbbVie Inc.
Xinjun Wang
Xutong Zhao	US Food and Drug Administration
Yalin Zhu	Merck & Co Inc.
Yang Song	Vertex Pharmaceuticals Inc.
Yangying Liu	Lehigh University
Yaoxiang Li	Georgetown University Medical Center
Yasuhiro Hagiwara	University of Tokyo
Yingying Liu	Biogen
Yiyue Lou	Vertex Pharmaceuticals Incorporated
Yu (Audrey) Zhao	US Food and Drug Administration
Yuan Wu	Duke University
Yuanyuan Bian	Eli Lilly and Company
Yueqin Zhao	US Food and Drug Administration
Yujia Sun	University of Manchester
Yun Li	University of Pennsylvania
Yu-Ting Weng	US Food and Drug Administration
Zhen Zhang
Zheng Li	Novartis Pharmaceuticals Corporation
Zhixing Xu	Sanofi-Aventis USA
Zhongkai Wang	Eli Lilly and Company
Ziwei Ma	University of Tennessee at Chattanooga College of Arts and Sciences

We also thank all our other reviewers who contributed their time and support to the journal, but who requested that we not include their names in this list.